SlideShare a Scribd company logo
Reaping the benefits of
technological advancements in
Optimizing the Drug Designing -
Pharmaceutical Conferences
OMICS Group
OMICS Group is delighted to invite you to attend the
2nd International Conference on Medicinal Chemistry
& Computer Aided Drug Designing, which is to be held
on October 15-17, 2013 at Las Vegas, USA.
144th OMICS Group Conference
2nd International Conference on
Medical chemistry & Computer Aided Drug Designing
October 15-17, 2013, Las Vegas, USA
MedChem & CADD-2013 is a remarkable event
which brings together pharmaceutical
companies, leading universities, small
biotechnology enterprises, government agencies
and research institutions to share
ideas, experiences, make connections and
evaluate emerging opportunities to create an
environment that will foster pharmaceutical
innovations. The scientific program will focus on
the current advances in the research field as well
as serve as a catalyst for the advancement of
Medicinal Chemistry and Drug Designing.
The 2nd International Conference on
Medicinal Chemistry & Computer Aided Drug
Designing will schedule and coordinate all
meetings with our Editorial Board Members
and other experts in various research fields
across the World. The scientific program paves
a way to gather visionaries through the
research talks and presentations, and also
puts forward many thought provoking
strategies about Medicinal Chemistry and
Drug Designing.
Medicinal chemistry is a discipline with a
traditional focus on ‘Organic Synthetic
Chemistry’ which aims at drug discovery and
optimization. Compounds used as medicines
are mostly organic compounds that are
broadly classified as small organic molecules
and biologics. Biologics are the proteins used
in medicinal preparations.
• Computer Aided Drug Design Advancements in
the fields of biochemistry, molecular and cell
biology, facilitated by the developments in
genomics and proteomics are instrumental in the
rapid design and production of drugs.
Computational chemistry is used in ‘Computer
Aided Drug Designing’.
• In order to reap the benefits of scientific and the
technological advancements in the fields of
Medicinal Chemistry and therapeutic studies,
OMICS Group has announced MedChem & CADD-
2013.
It is a remarkable event which aims to bring
pharmaceutical companies, leading
universities, small biotechnology
enterprises, government agencies and research
institutions together to share
ideas, experiences, make connections and
evaluate emerging opportunities to create an
environment that will foster pharmaceutical
innovations. The scientific program will focus on
the current advances in the research field as well
as serve as a catalyst for the advancement of
Medicinal Chemistry & Drug Designing.
Key Speakers at the Event
• Victor J Hruby, Regents Professor, University of
Arizona, USA
• Xiaoqi Chen Amgen, USA
• Alexander Heifetz, Principal Scientist, Evotec
Ltd.UK
• Mitsuji Yamashita Shizuoka University, Japan
Major Tracks at the event include
• Rational Drug Designing
• Computer-Aided Drug Design and Structure Determination
• Quantitative Structure-Activity Relationships
• Drug Development and Delivery System
• Drug Discovery
• Drug Interactions
• Pharmacotherapy
• Pharmacognosy
• Pharmacogenomics and Pharmacogenetics
• Receptors and Inhibitors
• Drug Safety and Regulations
• Recent Research and Developments
Venue & Hospitality
The Official Attendee Housing Site for the 2nd
International Conference on Medicinal
Chemistry & Computer Aided Drug Designing,
which will be held in the beautiful and exciting
city of Las Vegas, USA. The conference will
take place in the following dates and
locations.
Conference Dates: October 15-17, 2013
Hampton Inn Tropicana
4975 South Dean Martin Drive
Las Vegas, Nevada
United States 89118
Tel: 1-702-948-8100
Fax: 1-702-948-8101
For more details on Earth Science &
Climate Change conference, please
visit
http://www.omicsgroup.com/ea
rth-science-climate-change-
conference-2014/
For further details contact
Adam Benson
MedChem & CADD-2013 Organizing Committee
Pharmaceutical Conferences
2360 Corporate Circle
Suite 400, Henderson
NV 89074-7722, USA
Phone: +1-888-843-8169
Fax: +1-650-618-1417
Toll Free: +1-800-216-6499
E-mail: medchem2013@omicsonline.net /
medchem2013@omicsonline.com
http://www.omicsonline.org/contact.php

More Related Content

What's hot

HCF 2019 Panel 3: Marco Camboni
HCF 2019 Panel 3: Marco CamboniHCF 2019 Panel 3: Marco Camboni
HCF 2019 Panel 3: Marco Camboni
Chemicals Forum Association
 
HCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas BallHCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas Ball
Chemicals Forum Association
 
HCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de BruijnHCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de Bruijn
Chemicals Forum Association
 
HCF 2019 Panel 3: Daren Kelland
HCF 2019 Panel 3: Daren KellandHCF 2019 Panel 3: Daren Kelland
HCF 2019 Panel 3: Daren Kelland
Chemicals Forum Association
 
Go to the market
Go to the marketGo to the market
Go to the market
ProFAX
 
HCF 2019 Panel 5: Mike Rasenberg
HCF 2019 Panel 5: Mike RasenbergHCF 2019 Panel 5: Mike Rasenberg
HCF 2019 Panel 5: Mike Rasenberg
Chemicals Forum Association
 
HCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De SchamphelaereHCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De Schamphelaere
Chemicals Forum Association
 
June 9 2017 Panel 4 Brian Richards
June 9 2017 Panel 4 Brian RichardsJune 9 2017 Panel 4 Brian Richards
June 9 2017 Panel 4 Brian Richards
Chemicals Forum Association
 
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
Andrew McEachran
 
HCF 2016: Johanna Peltola-Thies
HCF 2016: Johanna Peltola-ThiesHCF 2016: Johanna Peltola-Thies
HCF 2016: Johanna Peltola-Thies
Chemicals Forum Association
 
Domainex Genesis Award
Domainex   Genesis AwardDomainex   Genesis Award
Domainex Genesis Award
Joanne McCudden
 
Domainex Genesis Award
Domainex Genesis AwardDomainex Genesis Award
Domainex Genesis Awardpfallon
 
HCF 2018 Panel 3: Micheal Walls
HCF 2018 Panel 3: Micheal WallsHCF 2018 Panel 3: Micheal Walls
HCF 2018 Panel 3: Micheal Walls
Chemicals Forum Association
 
Targos AKESOgen Strategic Partnership to enable a comprehensive biomarker ser...
Targos AKESOgen Strategic Partnership to enable a comprehensive biomarker ser...Targos AKESOgen Strategic Partnership to enable a comprehensive biomarker ser...
Targos AKESOgen Strategic Partnership to enable a comprehensive biomarker ser...Targos Inc, San Bruno, California
 
HCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike SchadeHCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike Schade
Chemicals Forum Association
 
Post-Market Surveillance Activities to Ensure the Safe Use of Medical Devices
Post-Market Surveillance Activities to Ensure the Safe Use of Medical DevicesPost-Market Surveillance Activities to Ensure the Safe Use of Medical Devices
Post-Market Surveillance Activities to Ensure the Safe Use of Medical Devices
UN SPHS
 
June 8 2017 Panel 2 Ricardo Barra
June 8 2017 Panel 2 Ricardo BarraJune 8 2017 Panel 2 Ricardo Barra
June 8 2017 Panel 2 Ricardo Barra
Chemicals Forum Association
 
HCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka MalmHCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka Malm
Chemicals Forum Association
 
HCF 2019 Panel 3: Elena Montani
HCF 2019 Panel 3: Elena MontaniHCF 2019 Panel 3: Elena Montani
HCF 2019 Panel 3: Elena Montani
Chemicals Forum Association
 
June 9 2017 Panel 5 Karin Kilian
June 9 2017 Panel 5 Karin KilianJune 9 2017 Panel 5 Karin Kilian
June 9 2017 Panel 5 Karin Kilian
Chemicals Forum Association
 

What's hot (20)

HCF 2019 Panel 3: Marco Camboni
HCF 2019 Panel 3: Marco CamboniHCF 2019 Panel 3: Marco Camboni
HCF 2019 Panel 3: Marco Camboni
 
HCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas BallHCF 2019 Panel 5: Nicolas Ball
HCF 2019 Panel 5: Nicolas Ball
 
HCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de BruijnHCF 2019 Panel 2: Jack de Bruijn
HCF 2019 Panel 2: Jack de Bruijn
 
HCF 2019 Panel 3: Daren Kelland
HCF 2019 Panel 3: Daren KellandHCF 2019 Panel 3: Daren Kelland
HCF 2019 Panel 3: Daren Kelland
 
Go to the market
Go to the marketGo to the market
Go to the market
 
HCF 2019 Panel 5: Mike Rasenberg
HCF 2019 Panel 5: Mike RasenbergHCF 2019 Panel 5: Mike Rasenberg
HCF 2019 Panel 5: Mike Rasenberg
 
HCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De SchamphelaereHCF 2019 Panel 5: Karel De Schamphelaere
HCF 2019 Panel 5: Karel De Schamphelaere
 
June 9 2017 Panel 4 Brian Richards
June 9 2017 Panel 4 Brian RichardsJune 9 2017 Panel 4 Brian Richards
June 9 2017 Panel 4 Brian Richards
 
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...
 
HCF 2016: Johanna Peltola-Thies
HCF 2016: Johanna Peltola-ThiesHCF 2016: Johanna Peltola-Thies
HCF 2016: Johanna Peltola-Thies
 
Domainex Genesis Award
Domainex   Genesis AwardDomainex   Genesis Award
Domainex Genesis Award
 
Domainex Genesis Award
Domainex Genesis AwardDomainex Genesis Award
Domainex Genesis Award
 
HCF 2018 Panel 3: Micheal Walls
HCF 2018 Panel 3: Micheal WallsHCF 2018 Panel 3: Micheal Walls
HCF 2018 Panel 3: Micheal Walls
 
Targos AKESOgen Strategic Partnership to enable a comprehensive biomarker ser...
Targos AKESOgen Strategic Partnership to enable a comprehensive biomarker ser...Targos AKESOgen Strategic Partnership to enable a comprehensive biomarker ser...
Targos AKESOgen Strategic Partnership to enable a comprehensive biomarker ser...
 
HCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike SchadeHCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike Schade
 
Post-Market Surveillance Activities to Ensure the Safe Use of Medical Devices
Post-Market Surveillance Activities to Ensure the Safe Use of Medical DevicesPost-Market Surveillance Activities to Ensure the Safe Use of Medical Devices
Post-Market Surveillance Activities to Ensure the Safe Use of Medical Devices
 
June 8 2017 Panel 2 Ricardo Barra
June 8 2017 Panel 2 Ricardo BarraJune 8 2017 Panel 2 Ricardo Barra
June 8 2017 Panel 2 Ricardo Barra
 
HCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka MalmHCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka Malm
 
HCF 2019 Panel 3: Elena Montani
HCF 2019 Panel 3: Elena MontaniHCF 2019 Panel 3: Elena Montani
HCF 2019 Panel 3: Elena Montani
 
June 9 2017 Panel 5 Karin Kilian
June 9 2017 Panel 5 Karin KilianJune 9 2017 Panel 5 Karin Kilian
June 9 2017 Panel 5 Karin Kilian
 

Viewers also liked

Conference on Medicinal Chemistry & Computer Aided Drug Designing
Conference on Medicinal Chemistry & Computer Aided Drug DesigningConference on Medicinal Chemistry & Computer Aided Drug Designing
Conference on Medicinal Chemistry & Computer Aided Drug Designing
OMICS International
 
Computer aided drug designing (CADD)
Computer aided drug designing (CADD)Computer aided drug designing (CADD)
Computer aided drug designing (CADD)
Aakshay Subramaniam
 
Computer aided drug designing
Computer aided drug designingComputer aided drug designing
Computer aided drug designing
Muhammed sadiq
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug designN K
 
The Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsThe Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post Formats
Barry Feldman
 
The Outcome Economy
The Outcome EconomyThe Outcome Economy
The Outcome Economy
Helge Tennø
 

Viewers also liked (7)

Conference on Medicinal Chemistry & Computer Aided Drug Designing
Conference on Medicinal Chemistry & Computer Aided Drug DesigningConference on Medicinal Chemistry & Computer Aided Drug Designing
Conference on Medicinal Chemistry & Computer Aided Drug Designing
 
Computer aided drug designing (CADD)
Computer aided drug designing (CADD)Computer aided drug designing (CADD)
Computer aided drug designing (CADD)
 
Computer aided drug designing
Computer aided drug designingComputer aided drug designing
Computer aided drug designing
 
Computer Aided Drug Design ppt
Computer Aided Drug Design pptComputer Aided Drug Design ppt
Computer Aided Drug Design ppt
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug design
 
The Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsThe Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post Formats
 
The Outcome Economy
The Outcome EconomyThe Outcome Economy
The Outcome Economy
 

Similar to Medicinal chemistry & computer aided drug designing

Strand genomics features in CIO review
Strand genomics features in CIO reviewStrand genomics features in CIO review
Strand genomics features in CIO review
Strand Life Sciences Pvt Ltd
 
Building a Culture of Model-driven Drug Discovery at Merck
Building a Culture of Model-driven Drug Discovery at MerckBuilding a Culture of Model-driven Drug Discovery at Merck
Building a Culture of Model-driven Drug Discovery at Merck
Chris Waller
 
Building a Culture
Building a CultureBuilding a Culture
Building a CultureChris Waller
 
In silico Drug Design: Prospective for Drug Lead Discovery
In silico Drug Design: Prospective for Drug Lead DiscoveryIn silico Drug Design: Prospective for Drug Lead Discovery
In silico Drug Design: Prospective for Drug Lead Discovery
inventionjournals
 
Journal of Pharmaceutical Regulatory Affairs
Journal of Pharmaceutical Regulatory AffairsJournal of Pharmaceutical Regulatory Affairs
Journal of Pharmaceutical Regulatory Affairs
OMICS International
 
Wk 5 case 1 designing drug virtually
Wk 5 case 1 designing drug virtually Wk 5 case 1 designing drug virtually
Wk 5 case 1 designing drug virtually
dyadelm
 
Case 5.1 - DESIGNING DRUGS VIRTUALLY
Case 5.1 - DESIGNING DRUGS VIRTUALLYCase 5.1 - DESIGNING DRUGS VIRTUALLY
Case 5.1 - DESIGNING DRUGS VIRTUALLY
Aya Wan Idris
 
Various Computational Tools used in Drug Design
Various Computational Tools used in Drug DesignVarious Computational Tools used in Drug Design
Various Computational Tools used in Drug Design
FirujAhmed2
 
Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...
Antti Haapalinna
 
Role of bioinformatics and pharmacogenomics in drug discovery
Role of bioinformatics and pharmacogenomics in drug discoveryRole of bioinformatics and pharmacogenomics in drug discovery
Role of bioinformatics and pharmacogenomics in drug discovery
Arindam Chakraborty
 
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
Nejmeddine Jemaa
 
Epidemiology and Evolutionary Genetics
Epidemiology and Evolutionary GeneticsEpidemiology and Evolutionary Genetics
Epidemiology and Evolutionary Genetics
OMICS Group | International Science Conferences
 
Conferences
ConferencesConferences
Eric mann - Health Technology Forum - final 2013-06-26
Eric mann  - Health Technology Forum - final 2013-06-26Eric mann  - Health Technology Forum - final 2013-06-26
Eric mann - Health Technology Forum - final 2013-06-26
Eric Mann
 
Organs-On-Chips - 2017 Report by Yole Developpement
Organs-On-Chips - 2017 Report by Yole DeveloppementOrgans-On-Chips - 2017 Report by Yole Developpement
Organs-On-Chips - 2017 Report by Yole Developpement
Yole Developpement
 
Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...
Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...
Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...
Linde Gas Benelux
 
Medical Device-Polymers & Plastics
Medical Device-Polymers & PlasticsMedical Device-Polymers & Plastics
Medical Device-Polymers & Plastics
InnoPlast Solutions
 
Precision Medicine & Biomarkers Leaders Summit - Boston USA - 7th & 8th May
Precision Medicine & Biomarkers Leaders Summit - Boston USA - 7th & 8th MayPrecision Medicine & Biomarkers Leaders Summit - Boston USA - 7th & 8th May
Precision Medicine & Biomarkers Leaders Summit - Boston USA - 7th & 8th May
Tony Couch
 

Similar to Medicinal chemistry & computer aided drug designing (20)

Strand genomics features in CIO review
Strand genomics features in CIO reviewStrand genomics features in CIO review
Strand genomics features in CIO review
 
Building a Culture of Model-driven Drug Discovery at Merck
Building a Culture of Model-driven Drug Discovery at MerckBuilding a Culture of Model-driven Drug Discovery at Merck
Building a Culture of Model-driven Drug Discovery at Merck
 
Building a Culture
Building a CultureBuilding a Culture
Building a Culture
 
Drug Regulatory Affairs pdf
Drug Regulatory Affairs pdfDrug Regulatory Affairs pdf
Drug Regulatory Affairs pdf
 
In silico Drug Design: Prospective for Drug Lead Discovery
In silico Drug Design: Prospective for Drug Lead DiscoveryIn silico Drug Design: Prospective for Drug Lead Discovery
In silico Drug Design: Prospective for Drug Lead Discovery
 
Journal of Pharmaceutical Regulatory Affairs
Journal of Pharmaceutical Regulatory AffairsJournal of Pharmaceutical Regulatory Affairs
Journal of Pharmaceutical Regulatory Affairs
 
pc14164_brochure-1
pc14164_brochure-1pc14164_brochure-1
pc14164_brochure-1
 
Wk 5 case 1 designing drug virtually
Wk 5 case 1 designing drug virtually Wk 5 case 1 designing drug virtually
Wk 5 case 1 designing drug virtually
 
Case 5.1 - DESIGNING DRUGS VIRTUALLY
Case 5.1 - DESIGNING DRUGS VIRTUALLYCase 5.1 - DESIGNING DRUGS VIRTUALLY
Case 5.1 - DESIGNING DRUGS VIRTUALLY
 
Various Computational Tools used in Drug Design
Various Computational Tools used in Drug DesignVarious Computational Tools used in Drug Design
Various Computational Tools used in Drug Design
 
Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...
 
Role of bioinformatics and pharmacogenomics in drug discovery
Role of bioinformatics and pharmacogenomics in drug discoveryRole of bioinformatics and pharmacogenomics in drug discovery
Role of bioinformatics and pharmacogenomics in drug discovery
 
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
 
Epidemiology and Evolutionary Genetics
Epidemiology and Evolutionary GeneticsEpidemiology and Evolutionary Genetics
Epidemiology and Evolutionary Genetics
 
Conferences
ConferencesConferences
Conferences
 
Eric mann - Health Technology Forum - final 2013-06-26
Eric mann  - Health Technology Forum - final 2013-06-26Eric mann  - Health Technology Forum - final 2013-06-26
Eric mann - Health Technology Forum - final 2013-06-26
 
Organs-On-Chips - 2017 Report by Yole Developpement
Organs-On-Chips - 2017 Report by Yole DeveloppementOrgans-On-Chips - 2017 Report by Yole Developpement
Organs-On-Chips - 2017 Report by Yole Developpement
 
Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...
Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...
Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...
 
Medical Device-Polymers & Plastics
Medical Device-Polymers & PlasticsMedical Device-Polymers & Plastics
Medical Device-Polymers & Plastics
 
Precision Medicine & Biomarkers Leaders Summit - Boston USA - 7th & 8th May
Precision Medicine & Biomarkers Leaders Summit - Boston USA - 7th & 8th MayPrecision Medicine & Biomarkers Leaders Summit - Boston USA - 7th & 8th May
Precision Medicine & Biomarkers Leaders Summit - Boston USA - 7th & 8th May
 

Recently uploaded

Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 

Recently uploaded (20)

Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 

Medicinal chemistry & computer aided drug designing

  • 1. Reaping the benefits of technological advancements in Optimizing the Drug Designing - Pharmaceutical Conferences OMICS Group
  • 2. OMICS Group is delighted to invite you to attend the 2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing, which is to be held on October 15-17, 2013 at Las Vegas, USA. 144th OMICS Group Conference 2nd International Conference on Medical chemistry & Computer Aided Drug Designing October 15-17, 2013, Las Vegas, USA
  • 3. MedChem & CADD-2013 is a remarkable event which brings together pharmaceutical companies, leading universities, small biotechnology enterprises, government agencies and research institutions to share ideas, experiences, make connections and evaluate emerging opportunities to create an environment that will foster pharmaceutical innovations. The scientific program will focus on the current advances in the research field as well as serve as a catalyst for the advancement of Medicinal Chemistry and Drug Designing.
  • 4. The 2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing will schedule and coordinate all meetings with our Editorial Board Members and other experts in various research fields across the World. The scientific program paves a way to gather visionaries through the research talks and presentations, and also puts forward many thought provoking strategies about Medicinal Chemistry and Drug Designing.
  • 5. Medicinal chemistry is a discipline with a traditional focus on ‘Organic Synthetic Chemistry’ which aims at drug discovery and optimization. Compounds used as medicines are mostly organic compounds that are broadly classified as small organic molecules and biologics. Biologics are the proteins used in medicinal preparations.
  • 6. • Computer Aided Drug Design Advancements in the fields of biochemistry, molecular and cell biology, facilitated by the developments in genomics and proteomics are instrumental in the rapid design and production of drugs. Computational chemistry is used in ‘Computer Aided Drug Designing’. • In order to reap the benefits of scientific and the technological advancements in the fields of Medicinal Chemistry and therapeutic studies, OMICS Group has announced MedChem & CADD- 2013.
  • 7. It is a remarkable event which aims to bring pharmaceutical companies, leading universities, small biotechnology enterprises, government agencies and research institutions together to share ideas, experiences, make connections and evaluate emerging opportunities to create an environment that will foster pharmaceutical innovations. The scientific program will focus on the current advances in the research field as well as serve as a catalyst for the advancement of Medicinal Chemistry & Drug Designing.
  • 8. Key Speakers at the Event • Victor J Hruby, Regents Professor, University of Arizona, USA • Xiaoqi Chen Amgen, USA • Alexander Heifetz, Principal Scientist, Evotec Ltd.UK • Mitsuji Yamashita Shizuoka University, Japan
  • 9. Major Tracks at the event include • Rational Drug Designing • Computer-Aided Drug Design and Structure Determination • Quantitative Structure-Activity Relationships • Drug Development and Delivery System • Drug Discovery • Drug Interactions • Pharmacotherapy • Pharmacognosy • Pharmacogenomics and Pharmacogenetics • Receptors and Inhibitors • Drug Safety and Regulations • Recent Research and Developments
  • 10. Venue & Hospitality The Official Attendee Housing Site for the 2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing, which will be held in the beautiful and exciting city of Las Vegas, USA. The conference will take place in the following dates and locations.
  • 11. Conference Dates: October 15-17, 2013 Hampton Inn Tropicana 4975 South Dean Martin Drive Las Vegas, Nevada United States 89118 Tel: 1-702-948-8100 Fax: 1-702-948-8101
  • 12. For more details on Earth Science & Climate Change conference, please visit http://www.omicsgroup.com/ea rth-science-climate-change- conference-2014/
  • 13. For further details contact Adam Benson MedChem & CADD-2013 Organizing Committee Pharmaceutical Conferences 2360 Corporate Circle Suite 400, Henderson NV 89074-7722, USA Phone: +1-888-843-8169 Fax: +1-650-618-1417 Toll Free: +1-800-216-6499 E-mail: medchem2013@omicsonline.net / medchem2013@omicsonline.com http://www.omicsonline.org/contact.php